NEW YORK, Aug. 7, 2014 /PRNewswire/ — PositiveID Corp. (OTCQB: PSID), with offices in Delray Beach, FL and Pleasanton, CA, is an emerging player in the biothreat detection market. The recent high visibility Ebola outbreak has created significant alarm among government officials as well as industry experts with a steady stream of media coverage flowing out over the last several days as the public follows the story closely. A number of industry experts and potential contenders in the market for diagnostic testing products have surfaced with various opinions and potential solutions with varying degrees of applicability to the near term problem at hand; preventing uncontrolled spread of Ebola (and other bio-threats) that could result in a pandemic or other major public health crisis.
PSID has a potentially game changing disruptive technology without any apparent current competition. Currently state of the art Ebola tests use polymerase chain reaction (PCR) a molecular diagnostic technology used to amplify a single or a few copies of a piece of DNA across several orders of magnitude. Expedited test results currently must be sent to a lab and take about 8 hours to turn around. PSID Firefly handheld technology may be able to produce valid test results on site eliminating the need to send samples to a lab and simultaneously reduce the total time for a result to 30 minutes. Reductions in testing time of that magnitude combined with eliminating the need to send samples to a lab would be truly revolutionary.
The Company issued revenue guidance through the end of 2015 of $4-10 million (combined between 2014 and 2015), $3.5 million of which is already in backlog. The Company is scheduled to report financial results in August and high sector visibility combined with more information on Company fundamentals should increase interest in PSID.
An analyst report which details the current situation, an overview of the company and analyst comments can be viewed in its entirety by using the link below. There is no cost obligation required to view this report:
copy and paste to browser may be required.
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is written and authored by Michael Anderegg, Chartered Financial Analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.
A full disclaimer can be found by viewing the full analyst report.
If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at firstname.lastname@example.org. For any urgent concerns or inquiries please contact us at email@example.com.